It's time to think twice about eye lash extensions, eye lash curlers and mascaras that promise longer, darker and thicker eyelashes. Latisse, manufactured by Allergan, has been launched with success to produce dark, full, lengthy eyelashes. Latisse is the only FDA approved treatment for hypotrichosis to grow eyelashes.
Latisse is a new solution for hypotrichosis, a condition in which the eyelashes do not grow. Hypotrichosis may be caused by inappropriate genetic development or it can be the symptom of another more serious medical condition. Numerous medical conditions have been linked to hypotrichosis, including, but not limited to: Graham-Little Syndrome, Hallermann-Streiff Syndrome (from chemotherapy treatment), Ofuji Syndrome, and certain types of chondrodysplasia.
Side Effects of Latisse
Latisse is a prescription medication that must be obtained through a physician. Physicians screen people interested in Latisse to help ensure that they are not at risk for side effects and monitor the use of Latisse.
Side effects have been reported in some people using Latisse. They include:
- eye irritation
- dry eyes
- temporary darkening of skin
Allergan provides an applicator for the application of Latisse in order to reduce the risk of the substance coming in contact with an area of the skin.
Other types of eyelash growers have been on the market, but several have been removed because of side effects such as:
- optic-nerve damage
- retinal swelling
- eye inflammation
- impaired vision
Such side effects have not been linked to Latisse. In fact, over-the-counter and online eyelash growers are not required to go through clinical study or FDA approval processes. Only prescription medications fall into the approval process category. Latisse has met FDA criteria for safety and efficacy.